🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well ixazomib and rituximab work in treatin...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2019-08-28
Trial ID
NCT04047797
Treatments Being Tested
This phase II trial studies the side effects and best dose of bortezomib wh...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2007-02-13
Trial ID
NCT00439556
This phase II trial studies how well polatuzumab vedotin and combination ch...
Status
Active Not Recruiting
Location
Karmanos Cancer Institute
Start Date
2020-08-21
Trial ID
NCT04479267
This trial is to evaluate if dexrazoxane is safer and more effective than l...
Status
Recruiting
Location
Beth Israel Deaconess Medical Center
Start Date
2026-08-31
Trial ID
NCT07654426
This phase I/II trial studies the side effects and best dose of lenalidomid...
Status
Unknown
Location
Mayo Clinic in Florida
Start Date
2016-05-20
Trial ID
NCT02628405
Treatments Being Tested
This pilot phase I trial studies the side effects of engineered donor stem ...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2017-01-18
Trial ID
NCT02960646
This was a randomized, double-blind, active-controlled, multiple-dose, clin...
Status
Completed
Location
Research Site
Start Date
2016-05-25
Trial ID
NCT02747043
This phase I trial studies the best dose and how well bendamustine works wi...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2009-02-17
Trial ID
NCT00880815
This phase II trial tests the effectiveness of golcadomide and rituximab as...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2025-04-02
Trial ID
NCT06834373
This phase I trial evaluates the best dose, possible benefits and/or side e...
Status
Recruiting
Location
University of California Davis Comprehensive Cancer Center
Start Date
2021-09-17
Trial ID
NCT05052528
Treatments Being Tested